Home » Authors » John Brosky

Articles by John Brosky

SYNTAX creates common ground for coronary risk assessment

Sep. 3, 2010

Guidelines praise new tech, but give stents short shrift

Sep. 2, 2010

GE unit sees $1 billion opportunity in healthcare reform market

Sep. 1, 2010

German IVD for cervical cancer aims to disrupt U.S. market

Aug. 23, 2010

Report from Europe: GE unit sees $1B opportunity in healthcare reform market

Aug. 4, 2010

Tale of two citations:Value of med-tech depends on agenda

Aug. 1, 2010

Report from Europe: Micro-optimism detected among nano manufacturers

July 22, 2010

Report from Europe: Tale of two citations: Value of med-tech depends on agenda

July 21, 2010

Report from Europe: IPO for Carmat's artificial heart exceeds expectations

July 9, 2010

Compelling registry results help to clinch clinical case for TAVI

July 1, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...